Neuronetics Launches Underwritten Stock Offering to Fund Perceptive Paydown
STIM has more than doubled off its 52-week low of $0.8.
Summary
Neuronetics launched an underwritten common stock offering to fund a partial repayment of its $65 million Perceptive term loan and general corporate purposes, days after warning of going-concern doubt and negotiating covenant relief contingent on a $15 million prepayment by November 30, 2026. Pricing and share count are not yet set.
Updates
· Reuters — Neuronetics priced its underwritten offering of 18,750,000 shares at $1.60 per share, raising $30 million.
Key Events · Financing and Capital Events · STIM
-
Underwritten Common Stock Offering Launched
Preliminary prospectus supplement dated November 10, 2026 for an underwritten offering of new common stock by the company; share count, price and proceeds are left blank pending pricing. Last reported sale price was $2.18 on November 9, 2026.
-
Proceeds Tied to Perceptive Paydown
A portion of net proceeds will repay outstanding term loans under the Perceptive Facility, where $65 million in aggregate principal was outstanding as of September 30, 2026 at an 11.5% rate, plus general corporate purposes.
-
Covenant Relief Hinges on $15M Prepayment
The Perceptive Sixth Amendment modifies revenue covenants only if the company prepays at least $15,000,000 plus accrued interest, fees and expenses; it automatically terminates if conditions are not met by November 30, 2026.
-
Going-Concern Doubt Disclosed
The filing states substantial doubt about the ability to continue as a going concern, based on projected trailing twelve-month revenue for the period ended March 31, 2027 falling below the pre-amendment minimum revenue covenant.
Analysis · STIM · Industrial Applications And Services
Neuronetics is selling new common stock in an underwritten deal, with proceeds earmarked to repay part of the $65 million Perceptive term loan plus general corporate purposes. The context matters: the 10-Q filed November 4 disclosed substantial doubt about going concern because the company expects to miss its March 31, 2027 revenue covenant, and the November 10 8-K says the covenant relief only sticks if the company prepays at least $15 million by November 30, 2026. This equity raise is the funding mechanism for that prepayment — without it, the amendment terminates and the loan can be called. Pricing is not yet set (share count, price and proceeds are blank in this preliminary supplement), so the size of the dilution is unknown; the stock's last reported sale was $2.18 on November 9 versus $1.81 today. The one offsetting detail is that certain directors indicated interest in buying at the public offering price, though those indications are non-binding.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, STIM was trading at $1.81 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $156.2M. The 52-week trading range was $0.80 to $3.44. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.